Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ectopic ACTH Secretion”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Ended earlyNCT00422201
What this trial is testing

Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

Who this might be right for
Cushing's Syndrome
HRA Pharma 18
Large-scale testing (Phase 3)Study completedNCT00569582
What this trial is testing

The Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 50
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Large-scale testing (Phase 3)Study completedNCT01371565
What this trial is testing

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's DiseaseCushing's Syndrome
Corcept Therapeutics 4
Testing effectiveness (Phase 2)Study completedNCT02468193
What this trial is testing

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Who this might be right for
Cushing's SyndromeEctopic Corticotropin SyndromeAdrenal Adenoma+3 more
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Looking for participantsNCT07104812
What this trial is testing

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Who this might be right for
Mild Autonomous Cortisol SecretionAutonomous Cortisol Secretion (ACS)
Mayo Clinic 15
Large-scale testing (Phase 3)Study completedNCT04308590
What this trial is testing

The Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas

Who this might be right for
Hypercortisolism
Corcept Therapeutics 137
Testing effectiveness (Phase 2)Active Not RecruitingNCT05804669
What this trial is testing

Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Who this might be right for
Cushing SyndromeCushing DiseaseEctopic ACTH Syndrome
Crinetics Pharmaceuticals Inc. 19
Not applicableEnded earlyNCT00796783
What this trial is testing

Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 2
Post-approval studies (Phase 4)Looking for participantsNCT07247058
What this trial is testing

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Who this might be right for
Mild Autonomous Cortisol Secretion (MACS)
Johns Hopkins University 10
Very early researchStudy completedNCT05361083
What this trial is testing

First-in-human Evaluation of [18F]CETO

Who this might be right for
Primary Aldosteronism Due to Aldosterone Producing AdenomaPrimary Aldosteronism Due to Nodular HyperplasiaAdrenal Cushing Syndrome+2 more
Uppsala University 20
Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337
Large-scale testing (Phase 3)Study completedNCT00936741
What this trial is testing

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138274
What this trial is testing

Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

Who this might be right for
Mild Autonomous Cortisol Secretion (MACS)Autonomous Cortisol Secretion (ACS)
Mayo Clinic 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06106295
What this trial is testing

Metyrapone for Mild Autonomous Cortisol Secretion (MACS)

Who this might be right for
Autonomous Cortisol SecretionMild Autonomous Cortisol Secretion (MACS)
Mayo Clinic 30
Not applicableStudy completedNCT03919734
What this trial is testing

Morbidity and Mortality in Autonomous Cortisol Secretion

Who this might be right for
Adrenal IncidentalomaCortisol Overproduction
Region Skane 4,596
Testing effectiveness (Phase 2)WithdrawnNCT02780882
What this trial is testing

SOM230 Ectopic ACTH-producing Tumors

Who this might be right for
Ectopic ACTH Syndrome
Cedars-Sinai Medical Center
Not applicableLooking for participantsNCT07361874
What this trial is testing

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

Who this might be right for
Mild Autonomous Cortisol Secretion (MACS)Autonomous Cortisol Secretion (ACS)Subclinical Cushing's+1 more
University of Texas Southwestern Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT05307328
What this trial is testing

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

Who this might be right for
Cushing's Syndrome ICushing Disease Due to Increased ACTH SecretionCortisol Excess+3 more
Sparrow Pharmaceuticals 26